Your browser doesn't support javascript.
loading
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway.
Wisløff, Torbjørn; White, Richard; Dalgard, Olav; Amundsen, Ellen J; Meijerink, Hinta; Løvlie, Astrid Louise; Kløvstad, Hilde.
Afiliação
  • Wisløff T; Department of Infectious Disease Epidemiology and Modelling, Norwegian Institute of Public Health, Oslo, Norway. twisloff@gmail.com.
  • White R; Department of Health Management and Health Economics, University of Oslo, Oslo, Norway. twisloff@gmail.com.
  • Dalgard O; Department of Infectious Disease Epidemiology and Modelling, Norwegian Institute of Public Health, Oslo, Norway.
  • Amundsen EJ; Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway.
  • Meijerink H; Division of Medicine and Laboratory Sciences, University of Oslo, Oslo, Norway.
  • Løvlie AL; Department of Substance Use, Norwegian Institute of Public Health, Oslo, Norway.
  • Kløvstad H; Department of Infectious Disease Epidemiology and Modelling, Norwegian Institute of Public Health, Oslo, Norway.
Pharmacoeconomics ; 36(5): 591-601, 2018 05.
Article em En | MEDLINE | ID: mdl-29396744
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Custos de Cuidados de Saúde / Análise Custo-Benefício / Hepatite C / Quimioterapia Combinada Tipo de estudo: Health_economic_evaluation Limite: Adult / Humans País como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Custos de Cuidados de Saúde / Análise Custo-Benefício / Hepatite C / Quimioterapia Combinada Tipo de estudo: Health_economic_evaluation Limite: Adult / Humans País como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article